From Equidate, Re-Named Forge Global, Boosts Series B to $85M:

Forge Global CEO Kelly Rodriques

Forge Global CEO Kelly Rodriques—

Photo courtesy of Forge Global

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

From Our Editors · Special Report
Xcelerating Life Sciences Boston: Special Report
Biopharma's Future in Digital Health

From Our Editors · Podcast
Xcelerating Life Sciences Philadelphia: The Highlights Podcast
Becoming the Cell & Gene Therapy Hub

Xconomy on Demand

We offer a number of ways to subscribe for free!